Greenwich LifeSciences, Inc.·4

Jan 2, 6:05 AM ET

Patel Snehal 4

4 · Greenwich LifeSciences, Inc. · Filed Jan 2, 2026

Insider Transaction Report

Form 4
Period: 2025-12-30
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
  • Purchase

    Common Stock

    2025-12-30$21.73/sh+2,900$63,0175,595,102 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4